Carsten Boess

Insider Reports History

Entity
Individual
Location
C/O Kiniksa Pharmaceuticals, Ltd., Clarendon House, 2 Church Street, Hamilton, Bermuda
Signature
/s/ Martin Wilson, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carsten Boess:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ROCKET PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 23.9K $360K $15.04 Jun 13, 2024 Direct
Avidity Biosciences, Inc. Director Stock Option (Right to Buy) 13.5K Jun 13, 2024 Direct

Insider Reports Filed by Carsten Boess

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RCKT ROCKET PHARMACEUTICALS, INC. Jun 13, 2024 1 $0 4 Jun 20, 2024 Director
RNA Avidity Biosciences, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
RCKT ROCKET PHARMACEUTICALS, INC. Jun 22, 2023 1 $0 4 Jun 26, 2023 Director
RNA Avidity Biosciences, Inc. Jun 15, 2023 1 $0 4 Jun 20, 2023 Director
RNA Avidity Biosciences, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
RCKT ROCKET PHARMACEUTICALS, INC. Jun 13, 2022 1 $0 4 Jun 15, 2022 Director
RNA Avidity Biosciences, Inc. Jun 16, 2021 1 $0 4 Jun 16, 2021 Director
RCKT ROCKET PHARMACEUTICALS, INC. Jun 14, 2021 1 $0 4 Jun 16, 2021 Director